Monocast
( Montelukast Tablet )
Monocast is indicated for the prophylaxis and chronic treatment of asthma in adults and paediatric patients 12 months of age and older. Monocast is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and paediatric patients 2 years of age and older.
- Effectively controls inflammation and bronchoconstriction of asthma
- Ensures treatment confidence to the patients
- Improves lung functions without steroid related side effects
- Improves lung functions and reduces exacerbations in patients uncontrolled on ICS alone
- Confers ICS-sparing effects while maintaining clinical stability
- Ensures adherence to prescribed therapy
